World-first use of base-edited CAR T-cells to treat resistant leukaemia
12 December 2022
A patient with relapsed T-cell leukaemia has been given base-edited T-cells in a world-first use of a base-edited cell therapy, in a 鈥榖ench-to-bedside鈥� collaboration between researchers at 皇家华人, led by Professor Waseem Qasim and Great Ormond Street Hospital for Children (GOSH).
Close
